Sumatriptan 85mg + Naproxen 500mg Tablet in PCD pharma franchise in Hyderabad

Sumatriptan 85mg + Naproxen 500mg Tablet in pharmaceutical manufacturing company in Mumbai

Sumatriptan 85mg + Naproxen 500mg Tablet in pain relief pharma franchise in Pune

Sumatriptan 85mg + Naproxen 500mg Tablet in pharma suppliers in Delhi

Sumatriptan 85mg + Naproxen 500mg Tablet in pharma export companies in Kolkata
Naprohike S Tablet in migraine and pain relief pharma franchise opportunities in Bengaluru

Home/Products /sumatriptan-85-mg-naproxen-500-mg-tablet

About the Product

Description


Naprohike S Tablet is a dual-action formulation combining Sumatriptan 85mg, a selective serotonin (5-HT1) receptor agonist, with Naproxen 500mg, a non-steroidal anti-inflammatory drug (NSAID). Sumatriptan works by constricting cranial blood vessels and blocking pain signals in the brain, making it effective for acute migraine relief. Naproxen reduces inflammation and inhibits prostaglandin synthesis, further enhancing pain relief. Together, this combination targets both vascular and inflammatory pathways of migraine, offering fast and sustained symptom control.

Common side effects may include dizziness, fatigue, dry mouth, nausea, and abdominal discomfort. Rarely, patients may experience chest pressure, palpitations, or allergic reactions. Both active ingredients can affect the cardiovascular or gastrointestinal system, so medical guidance is essential for patients with related conditions.

Naprohike S is indicated for the acute treatment of migraine attacks, with or without aura, in adults. It helps relieve headache, nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound), and is particularly useful in cases where standard painkillers alone are insufficient for migraine relief.

This medication is intended for acute migraine episodes and should not be used for migraine prevention. It should be taken at the onset of symptoms and not as a routine painkiller. Avoid use in patients with heart disease, uncontrolled hypertension, peptic ulcers, or a history of stroke. Use only under medical supervision.

Store in a cool, dry place below 25°C. Keep away from direct sunlight and moisture. Ensure it is stored out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Sumatriptan 85mg + Naproxen 500mg Tablet in the PCD pharma franchise market?

This combination has strong demand in the neurology, pain management, and anti-migraine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on CNS and specialty acute-care portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for effective migraine management under medical supervision. Sumatriptan 85mg is a triptan-class medicine that helps relieve migraine attacks by acting on serotonin receptors Naproxen 500mg is an NSAID that reduces inflammation, pain, and associated migraine symptoms The combination provides dual-action relief (neurological + anti-inflammatory) for acute migraine management Commonly prescribed for moderate to severe migraine attacks This strengthens a strong neurology and pain-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sumatriptan + Naproxen Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from high prescription demand in neurology practice, strong repeat usage in migraine patients, reliable supply chain support, seasonal and chronic demand stability, and attractive margins in the CNS segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality products, and a dependable supply chain to grow their pharmaceutical business successfully.